PharmaShots | Incisive News in 3 Shots

Subscribe Now

K36 Therapeutics

K36 Therapeutics Receives $70M Series B Financing to Develop KTX-1001 to Treat Multiple Myeloma

K36 Therapeutics Receives $70M Series B Financing to Develop KTX-1001 to Treat Multiple Myeloma

June 29, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us